Epstein File EFTA01059022: Driver and Harvard University (DS9)

Epstein Index›Documents›EFTA01059022

💨IMPACT LEVEL 1 — MEH

Epstein File EFTA01059022: Driver and Harvard University (DS9)

CorrespondenceDate unavailableEFTA010590221 keyword hits

1

views

0

shares

0

reactions

0

persons

3

keywords

3

excerpts

Email correspondence discussing pharmaceutical market drivers, including FDA feedback on Lybrido and Lybridos medications and market performance of Addyi. The message references a Loeb Professor of Statistics at Harvard University and includes a forwarded message from Adriaan Tuiten regarding company valuation. The document appears to be business correspondence unrelated to criminal investigation.

👤 Named in This Document

No named persons linked yet

🔑 Evidence Keywords

driver Harvard University Harvard

📋 Key Excerpts3

PersonKeyword

Excerpt 1

A very positive **driver** is the recent feedback by the FDA and the issued Guideline for Industry by the FDA, giving Lybrido and Lybridos explicit advice

Excerpt 2

A negative **driver** could be the fact that Addyi appears to fail in the market (however this was not really a surprise for EB, given the safety warnings,

Excerpt 3

Loeb Professor of Statistics Department of Statistics, **Harvard** **University** Begin forwarded message: From: Adriaan Tuiten Subject: company valuation Date